The NCI Translational Science Meeting

NCI Translates - NCI Translational Science Meeting banner

Agenda

November 7–9, 2008 Meeting Agenda
Friday, November 7, 2008
Time	Event	Hotel Location
4:00 p.m.	Registration/Check-In	Independence Level
6:00 p.m.	Opening Joint Session Introductions — Dr. Sheila Prindiville *Welcoming Remarks and Overview* — Dr. John Niederhuber *The NCI Translational Science Meeting* — Dr. Lynn Matrisian *History of the Translational Research Working Group* — Dr. Ernest Hawk *Agents Pathway Example* — Dr. Kenneth Anderson *Biospecimens Pathway Example* — Dr. Brian Reid *Interface with the NCI Clinical Trials System* — Dr. James Doroshow	Constitution Ballroom
8:00 p.m.	Welcome Reception	Bridge Rooms
Saturday, November 8, 2008
Time	Event	Hotel Location
8:00 a.m.	Exhibit Hall (until 5:30 p.m.)	Independence A
8:00 a.m.	Concurrent Sessions I: Poster Viewing Posters showcase translational research in each poster session
	Agents Pathway — Biochemical Targets & Drug Screening Scientific Co-Chairs: Dr. Peter Houghton & Dr. Mien-Chie Hung Advocate Co-Chairs: Mr. Mark Dungan & Ms. Kay Kays	Independence A
	Agents Pathway — Cancer Stem Cell, Gene Expression, & Epigenetic Targets Scientific Co-Chairs: Dr. Steven Baylin & Dr. Curt Civin Advocate Co-Chairs: Ms. Laura Cleveland & Dr. James Omel	Independence H & I
	Biospecimen Pathway — Biomarkers for Hematological Malignancies & Pediatric Cancer Scientific Co-Chairs: Dr. Gregory Reaman & Dr. Soheil Meshinchi Advocate Co-Chairs: Mr. Kenneth Geihsler & Dr. Susan Weiner	Constitution C, D, & E
	Session: Biospecimen Pathway — -Omic Technology in Biomarker Discovery & Development Scientific Co-Chairs: Dr. Sam Hanash & Dr. Marc Ladanyi Advocate Co-Chairs: Ms. Diana Chingos & Ms. Paula Kim	Farragut/Lafayette
	Session: Biospecimen Pathway — Biomarkers for Prostate & Bladder Cancers Scientific Co-Chairs: Dr. David Rowley & Dr. Daniel Theodorescu Advocate Co-Chairs: Dr. Kristofer Prepelica & Ms. Diane Z. Quale	Wilson/Roosevelt/ Cabin John
	Session: Imaging Pathway — Imaging Approaches to Cancer Detection Scientific Co-Chairs: Dr. Sam Gambhir & Dr. Maryellen Giger Advocate Co-Chairs: Ms. Peggy Devine & Ms. Christie Pratt	Franklin/McPherson
	Session: Immune Response Modifier Pathway — Antibodies, Cytokines, & Viruses Scientific Co-Chairs: Dr. Louis Weiner & Dr. Madhav Dhodapkar Advocate Co-Chairs: Dr. Eric C. Perakslis & Ms. Patty Spears	Independence C, D, & E
	Session: Interventive Devices Pathway — Ionizing & Non-Ionizing Radiation Scientific Co-Chairs: Dr. Theodore Lawrence & Dr. John Wong Advocate Co-Chairs: Ms. Michelle Duff & Ms. Martha Gaines	Independence F & G
	Session: Lifestyle Pathway — Dietary Components in Cancer Prevention & Control Scientific Co-Chairs: Dr. Stephen Barnes & Dr. Henry Thompson Advocate Co-Chairs: Dr. Joyce W. Graff & Ms. Ardeth Obenauf	Renwick/Bulfinch/ Latrobe/Burnham
9:00 a.m.	Concurrent Poster Sessions I: Poster Discussion Co-chairs present an example translational research opportunity and demonstrate utilization of the applicable TRWG Developmental Pathway	Same as Poster Viewing
10:30 a.m.	Morning Break
11:00 a.m.	Concurrent Poster Sessions II: Poster Viewing Posters showcase translational research in each poster session
	Session: Agents Pathway — Drug Delivery & Gene Therapy Scientific Co-Chairs: Dr. H. Kim Lyerly & Dr. Jan Schnitzer Advocate Co-Chairs: Ms. Deborah Collyar & Ms. Mary J. Scroggins	Independence H & I
	Session: Agents Pathway — New Agents for the Treatment & Prevention of Prostate Cancer Scientific Co-Chairs: Dr. William Nelson & Dr. Kenneth Pienta Advocate Co-Chairs: Mr. Everett Dodson & Ms. Sandra Finestone	Wilson/Roosevelt/ Cabin John
	Session: Agents Pathway — Targeting Head, Neck, & Lung Cancers Scientific Co-Chairs: Dr. Jennifer Grandis & Dr. Ming You Advocate Co-Chairs: Dr. Jeanette M. Ferguson & Ms. Kim Norris	Constitution C, D, & E
	Session: Biospecimen Pathway — Biomarkers for Breast Cancer Scientific Co-Chairs: Dr. Joe Gray & Dr. Richard Cote Advocate Co-Chairs: Ms. Cindy Geoghegan & Ms. Ginny Mason	Independence C, D, & E
	Session: Biospecimen Pathway — Prognostic & Predictive Biomarkers Scientific Co-Chairs: Dr. David Carbone & Dr. Charles Perou Advocate Co-Chairs: Ms. Jane Perlmutter & Ms. Marion C. Thurnauer	Independence A
	Session: Imaging Pathway — Imaging & Cancer Therapeutics Scientific Co-Chairs: Dr. Charles Erlichman & Dr. David Mankoff Advocate Co-Chairs: Ms. Catherine Huffman & Ms. Patty Lee	Independence F & G
	Session: Immune Response Modifier Pathway — Cellular Therapy for Immune Response Modification Scientific Co-Chairs: Dr. Elizabeth Jaffee & Dr. John Kirkwood Advocate Co-Chairs: Dr. Anna M. Masellis & Dr. Kristofer Prepelica	Farragut/Lafayette
	Session: Interventive Devices Pathway — Devices for Surgery Ablation & Biopsy Scientific Co-Chairs: Dr. Theodore Lawrence & Dr. Gary Dorfman Advocate Co-Chairs: Ms. Michelle Duff & Ms. Martha E. Gaines	Franklin/McPherson
	Session: Lifestyle Pathway — Biobehavioral Mechanisms in Cancer Progression & Control Scientific Co-Chairs: Dr. Susan Lutgendorf & Dr. Deborah Bruner Advocate Co-Chairs: Ms. Patricia A. Goldman & Ms. Valerie Guild	Renwick/Bulfinch/ Latrobe/Burnham
12:00 noon	Lunch (on your own)
1:00 p.m.	Concurrent Poster Sessions II: Poster Discussion Co-chairs present an example translational research opportunity and demonstrate utilization of the applicable TRWG Developmental Pathway	Same as Poster Viewing
2:30 p.m.	Afternoon Break
3:00 p.m.	Concurrent Poster Sessions III: Poster Viewing Posters showcase translational research in each poster session
	Session: Agents Pathway — Novel Targets in Hematological Malignancies Scientific Co-Chairs: Dr. Kenneth Anderson & Dr. Kevin Shannon Advocate Co-Chairs: Mr. Andrew Madoff & Ms. Louise M. Perkins	Independence F & G
	Session: Agents Pathway — Integrative Biology: Bench to Bedside Scientific Co-Chairs: Dr. Elise Kohn & Dr. Thea Tlsty Advocate Co-Chairs: Ms. Lorre Lei Jackson & Ms. Kay Kays	Farragut/Lafayette
	Session: Agents Pathway — Therapeutics Targeting Pancreatic & Breast Cancer Scientific Co-Chairs: Dr. James Abbruzzese & Dr. Carlos Arteaga Advocate Co-Chairs: Ms. Lynne Cargen & Ms. Julie Fleshman	Independence H & I
	Session: Biospecimen Pathway — Biomarkers for Early Detection Scientific Co-Chairs: Dr. Sam Hanash & Dr. Paul Cairns Advocate Co-Chairs: Ms. Eunice Hostetter & Ms. Mary Lou Smith	Independence C, D, & E
	Session: Biospecimen Pathway — Esophagus, Colon, & Liver Cancers Scientific Co-Chairs: Dr. Brian Reid & Dr. Johanna Lampe Advocate Co-Chairs: Mr. Ronald Obenauf & Ms. Nancy Roach	Constitution C, D, & E
	Session: Biospecimen Pathway — Biomarkers for Lung Cancer Detection & Therapy Scientific Co-Chairs: Dr. John Minna & Dr. David Johnson Advocate Co-Chairs: Ms. Debra Violette & Ms. Debra Wymer	Wilson/Roosevelt/ Cabin John
	Session: Immune Response Modifier Pathway — Cancer Vaccines Scientific Co-Chairs: Dr. Mac Cheever & Dr. Olivera Finn Advocate Co-Chairs: Dr. Joan Darling & Ms. Kate O'Neill	Independence A
4:00 p.m.	Concurrent Poster Sessions III: Poster Discussion Co-chairs present an example translational research opportunity and demonstrate utilization of the applicable TRWG Developmental Pathway
5:30 p.m.	Adjourn
Sunday, November 9, 2008
Time	Event	Hotel Location
9:00 a.m.	Closing Joint Session Select presentations of translational research opportunities (one per TRWG pathway) — Chaired by Dr. Lynn Matrisian *Impact of Pathways in the Business and Technological World* — Dr. David Dilts Closing Remarks — Dr. Lynn Matrisian	Constitution Ballroom
11:00 a.m.	Meeting Adjourned

| | | |

A Service of the National Cancer Institute

November 7–9, 2008 Meeting Agenda

Friday, November 7, 2008

Saturday, November 8, 2008

Sunday, November 9, 2008

November 7–9, 2008
Meeting Agenda